Search Results - Paolo Gisondi

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case report

    A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case report by Sofia Antolini, Giorgia Scagliosi, Olta Veliaj, Antonio Carletto, Elena Fracassi, Paolo Gisondi

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    [Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]

    [Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis] by Paolo Gisondi, Andrea Chiricozzi, Marcello Pani, Massimiliano Povero, Luca Castello, Maria Paola Pedone, Kerry Noonan, Zhixiao Wang, Roberta Di Turi

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients

    Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients by Roberta Belli, Anna Dattolo, Francesca Sampogna, Emanuela Gubinelli, Daniela Lulli, Gaia Moretta, Emanuele Scala, Luca Sanna, Matteo Megna, Maria Vittoria Cannizzaro, Melania Parisi, Cecilia Luordi, Claudia Scarponi, Maria Quaranta, Maria Grazia Lolli, Lorena Silvestri, Paolo Gisondi, Giampiero Girolomoni, Sabatino Pallotta, Cristina Albanesi, Laura Mercurio, Stefania Madonna

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: